bioMérieux Investor Relations Material
Latest events
H2 2023
bioMérieux
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from bioMérieux S.A
Access all reports
bioMérieux S.A. is a worldwide leader in the manufacture, marketing, and distribution of in vitro diagnostics for human and animal health applications. With sales that exceeded €1 billion for the first time in 2016, bioMérieux offers close to 20,000 products marketed under the brand names of ELITechGroup Pharma-Vet, bioMérieux Analyzer, molecular subsidiaries TA Systems and RED-BioSys Medical Insurance Company; Immedica, a provider of managed clinical care programs; BioFire Defense LLC (a wholly owned subsidiary), an integrated forensic product line; BD and Embletta which are joint ventures with Becton Dickinson & Company and Synlab Holding S.r.l., respectively; AxioMed Life Technologies Inc., a US company owning the patents associated with knee joint replacement implants Actifuse Foot Fusion System (AFFS) and same named prostheses; and Emmesure Inc., launched in 2013 to develop enhanced solutions for clinical laboratories through collaborations with small companies.
Key slides for bioMérieux S.A
H1 2023
bioMérieux S.A
H1 2023
bioMérieux S.A
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇫🇷 France